This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
SS-31 administration significantly improved sepsis-induced organ dysfunctions, reduced oxidative stress markers, proinflammatory cytokines, and apoptosis, and increased survival in a cecal ligation and puncture sepsis model.
Why it matters
This study suggests that targeting mitochondrial oxidative stress with SS-31 could be a promising therapeutic strategy to prevent organ failure in sepsis, a major cause of death in critical care.
How the study worked
Sepsis was induced in animals using cecal ligation and puncture. SS-31 (5 mg/kg) or vehicle was administered intraperitoneally immediately and 5 hours after surgery. Various biochemical, histological, and survival analyses were performed to assess organ function and inflammation.
What this study cannot tell us
The study used an animal model, so results may not fully translate to humans. The exact molecular mechanisms of SS-31’s protective effects require further elucidation.
Read the original research
Protective Effects of Antioxidant Peptide SS-31 Against Multiple Organ Dysfunctions During Endotoxemia.
Inflammation, 39(1), 54-64
Citation
Li, Guoming; Wu, Jing; Li, Renqi; Yuan, Dong; Fan, Yunxia; Yang, Jianjun; Ji, Muhuo; Zhu, Sihai. (2016). Protective Effects of Antioxidant Peptide SS-31 Against Multiple Organ Dysfunctions During Endotoxemia.. Inflammation, 39(1), 54-64. https://doi.org/10.1007/s10753-015-0222-1